Copenhagen — Exiqon A/S today launched the miRSIGN™ miR-21 Oncogene assay, a Research Use Only kit for measuring miR-21 levels in relation to two reference microRNAs in formalin-fixed, paraffin-embedded (FFPE) tissue samples, and the miRSIGN™ Colon Cancer assay, a Research Use Only kit for determining the presence of cancer cells in FFPE colon tissue samples. […]

CARLSBAD, CA — International Stem Cell Corporation (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell-based therapies and biomedical products, announced today that the Court of Justice of the European Union (CJEU), the European Union’s highest court, has ruled in favor of the Company and that the Company’s core technology patent applications are not […]

CULVER CITY, CA — Indi Molecular, the maker of a synthetic replacement for monoclonal antibodies, today announced that it has entered into a co-development agreement with Sigma-Aldrich to explore the use of Indi Molecular’s PCC technology with Sigma-Aldrich’s line of biological tools. PCC (protein catalyzed capture) agent technology is a breakthrough process that produces synthetic […]

WOBURN, Mass. — Covaris, Inc. has introduced the truXTRAC FFPE RNA Kit. This newest innovation from Covaris extracts high quality RNA, suitable for Next Gen Sequencing (NGS), from FFPE tissue samples. NGS-quality is achieved by the use of Covaris’ patented Adaptive Focused Acoustics((R)) (AFA) Technology matched with an optimized reagent system. The truXTRAC FFPE RNA […]

ALAMEDA, Calif. — BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Angus C. Russell, former Chief Executive Officer of Shire plc, has been appointed to BioTime’s Board of Directors. Shire is a leading global specialty biopharmaceutical company. During Mr. Russell’s tenure […]

ALAMEDA, Calif. — BioTime, Inc. (NYSE MKT: BTX) today announced that its subsidiary ES Cell International Pte. Ltd. (“ESI”) and GE Healthcare (GEHC) have signed a set of license agreements through which GEHC received rights to ESI’s stem cell patents and ESI received rights to stem cell patents controlled by GEHC, in both cases for […]

Porvair Sciences low profile 96-well deep well plate achieves a storage volume of 1.1ml / well in a height of just 27 mm enabling more plates to be stacked or stored in a given space. Manufactured from extractables-free polypropylene in an ISO 10,000 approved clean room environment – Porvair low profile plates undergo extensive quality […]

At its December meeting, the Board of Directors (BoD) of Roche Holding recommended first proposals for approval by the AGM, scheduled for 3 March 2015. All current members of the BoD will stand for re-election: Name, Board member since: Dr. Christoph Franz (as Chairman), 2011 André Hoffmann, 1996 Professor Dr. Pius Baschera,2007 Professor Sir John […]

AMSBIO announces DNA-In™ Neuro – a new generation transfection reagent developed specifically for maximum nucleic acid delivery into neurons, typically achieving a 2-fold or greater improvement in efficiency over currently available competing reagents. Neurons are among the most difficult cell types to transfect. DNA-In™ Neuro Transfection Reagent offers researchers a cost effective, robust and easy-to-use […]

ST. LOUIS — Sigma-Aldrich Corporation (NASDAQ: SIAL) today issued the second annual State of Translational Research Survey Report, addressing challenges to the reproducibility of research within the academic translational research community. Sigma-Aldrich’s report, based on a survey conducted in concert with the Association for the Advancement of Science (AAAS) and the Academic Drug Discovery Consortium […]